Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Immunomedics Inc (NASDAQ:IMMU)

3.24
Delayed Data
As of Dec 02
 +0.10 / +3.18%
Today’s Change
1.61
Today|||52-Week Range
5.44
+5.54%
Year-to-Date
No recent news for Immunomedics Inc.

Today’s Trading

Previous close3.14
Today’s open3.13
Day’s range3.06 - 3.30
Volume1,550,397
Average volume (3 months)1,574,167
Market cap$343.3M
Dividend yield--
Data as of 12/02/2016

Growth & Valuation

Earnings growth (last year)-21.57%
Earnings growth (this year)+28.23%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-42.81%
P/E ratioNM
Price/Sales68.00
Price/Book--

Competitors

 Today’s
change
Today’s
% change
LNTHLantheus Holdings In...-0.05-0.54%
OXFDOxford Immunotec Glo...-0.16-1.07%
CLDXCelldex Therapeutics...-0.02-0.56%
VCYTVeracyte Inc-0.08-1.04%
Data as of 12/02/2016

Financials

Next reporting dateFebruary 8, 2017
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$3.2M
Annual profit (last year)-$59.0M
Net profit margin-1,825.93%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Scientific &
Patent Officer
David M. Goldenberg
President, Chief Executive Officer &
Director
Cynthia L. Sullivan
Corporate headquarters
Morris Plains, New Jersey

Forecasts


Search for Jobs